Quantinno Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.1M Buy
875,068
+170,317
+24% +$9.93M 0.09% 256
2025
Q4
$38M Buy
704,751
+200,685
+40% +$9.65M 0.08% 293
2025
Q3
$22.7M Buy
504,066
+105,221
+26% +$4.91M 0.06% 373
2025
Q2
$18.5M Buy
398,845
+37,028
+10% +$1.82M 0.08% 280
2025
Q1
$22.1M Buy
361,817
+108,909
+43% +$6.35M 0.14% 127
2024
Q4
$14.3M Buy
252,908
+54,104
+27% +$3.02M 0.14% 111
2024
Q3
$10.3M Buy
198,804
+76,976
+63% +$3.61M 0.13% 129
2024
Q2
$5.06M Sell
121,828
-39,627
-25% -$1.77M 0.09% 233
2024
Q1
$8.76M Buy
161,455
+78,786
+95% +$4.01M 0.19% 90
2023
Q4
$4.24M Sell
82,669
-36,287
-31% -$1.9M 0.15% 137
2023
Q3
$6.9M Buy
118,956
+23,998
+25% +$1.47M 0.31% 44
2023
Q2
$6.07M Buy
94,958
+5,653
+6% +$379K 0.35% 39
2023
Q1
$6.19M Buy
89,305
+4,762
+6% +$336K 0.41% 32
2022
Q4
$6.08M Buy
84,543
+58,644
+226% +$4.42M 0.45% 31
2022
Q3
$1.84M Buy
25,899
+3,299
+15% +$239K 0.24% 87
2022
Q2
$1.74M Buy
22,600
+6,712
+42% +$511K 0.25% 93
2022
Q1
$1.16M Buy
15,888
+5,364
+51% +$360K 0.18% 144
2021
Q4
$656K Buy
+10,524
New +$617K 0.12% 204
2019
Q1
Sell
-8,700
Closed -$452K 376
2018
Q4
$452K Buy
+8,700
New +$467K 0.37% 77

Other funds holding BMY

Quantinno Capital Management's BMY Position: Q1 2026 in Review

Quantinno Capital Management increased its Bristol-Myers Squibb (BMY) stake by 24% in Q1 2026, buying an estimated $9.93M and bringing the position to 875,068 shares worth $53.1M. The position accounts for 0.09% of the portfolio, ranked #256.

Quantinno Capital Management first reported a position in BMY in Q4 2018 and has held it in 19 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Quantinno Capital Management held 875,068 shares of Bristol-Myers Squibb worth $53.1M as of Q1 2026.
  • Quantinno Capital Management bought 170,317 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.93M.
  • Bristol-Myers Squibb made up 0.09% of Quantinno Capital Management's portfolio in Q1 2026, its #256 holding.
  • Quantinno Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 19 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.